[Skip to Content]
Myasthenia Gravis

Clinical Effects of Zilucoplan in Patients With Generalized Myasthenia Gravis

JAMA Neurology
Published Online: February 17, 2020 Audio Author Interview 23 min 54 sec
<title>Clinical Effects of Zilucoplan in Patients With Generalized Myasthenia Gravis</title>
Backward 15 Play Pause Forward 15
1x
0:00 / 0:00
Download MP3

Interview with James F. Howard, MD, author of Clinical Effects of Self-administered Subcutaneous Zilucoplan in Patients with Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial

Subscribe

Subscribe on your favorite podcast source to receive future episodes of this podcast.
Learn more about this JAMA Network podcast here

Related Articles

  1. Clinical Effects of Zilucoplan in Patients With Generalized Myasthenia Gravis

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

See More About

Myasthenia Gravis Neurology Neuromuscular Diseases
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Close
Close

Lookup An Activity

or

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue